NASDAQ · Medical - Devices

iRadimed Corporation (IRMD) Stock

$85.88 +0.48% NASDAQ: IRMD Healthcare

Valuation

MetricValue
Price$85.88
Market Cap$1.10B
P/E Ratio47.37
P/B Ratio10.83
P/S Ratio12.77
EPS (TTM)$1.83
52-Week High$107.90
52-Week Low$68.68
Dividend Yield0.93%

Financials & Margins

MetricValue
ROE23.45%
ROA20.05%
ROCE26.04%
Gross Margin76.84%
Operating Margin32.40%
Net Margin26.70%
Debt/Equity0.00
Current Ratio8.10

Annual Financials (USD)

Metric20212022202320242025
Revenue$42.0M$53.0M$66.0M$73.0M$84.0M
Operating Profit$10.0M$16.0M$20.0M$22.0M$26.0M
Net Profit$9.0M$13.0M$17.0M$19.0M$22.0M
EPS$0.74$1.02$1.35$1.50$1.75
Op Margin23.5%29.3%30.6%30.0%31.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$83.0M$86.0M$92.0M$98.0M$109.0M
Total Liabilities$11.0M$12.0M$21.0M$12.0M$14.0M
Cash$62.0M$58.0M$50.0M$52.0M$51.0M
Borrowings$2.0M$2.0M$2.0M$0$0

Latest News

Iradimed Insider Sold Shares Worth $285,000, According to a Recent SEC Filing MT Newswires · Jun 4, 2026 Assessing IRADIMED (IRMD) Valuation After Strong Multi Year Returns And A Premium P/E Multiple Simply Wall St. · Jun 3, 2026 IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It Motley Fool · Jun 2, 2026 Iradimed Insider Sold Shares Worth $691,044, According to a Recent SEC Filing MT Newswires · May 28, 2026 Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report Insider Monkey · May 27, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$11.0M$10.0M$13.0M$26.0M$25.0M
Investing Cash Flow$0$-3.0M$-16.0M$-17.0M$-16.0M
Financing Cash Flow$0$0$0$-1.0M$-3.0M
Net Cash Flow$12.0M$-4.0M$-8.0M$2.0M$-1.0M
Free Cash Flow$11.0M$8.0M$5.0M$18.0M$17.0M

Valuation & Return Ratios

MetricValue
PEG Ratio4.06
EV / EBITDA33.53
FCF Yield2.26%
Quick Ratio8.13
Interest Coverage0.00
Return 1Y66.96%
Return 3Y116.15%
Return 5Y199.20%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $340.42 +1.11% 38.93 $5.00T 0.32%
MSFTMicrosoft Corporation $522.61 -1.35% 28.68 $3.88T 0.76%
GOOGLAlphabet Inc. $348.29 -0.63% 16.94 $4.22T 0.26%
AMZNAmazon.com, Inc. $254.06 -2.25% 19.82 $2.73T 0.00%
METAMeta Platforms, Inc. $720.89 -0.06% 27.93 $1.84T 0.28%

About iRadimed Corporation

iRadimed Corporation is led by CEO Roger E. Susi, employs 160 people, headquartered in US, publicly traded since 2014.

iRadimed Corporation (IRMD) stock trades at $85.88 with a market capitalization of $1.10B. The stock is valued at a price-to-earnings (P/E) ratio of 47.37, price-to-book of 10.83, price-to-sales of 12.77. Over the past 52 weeks the stock has ranged between $68.68 and $107.90, and currently trades 20.4% below its 52-week high. It pays a dividend yielding 0.93%.

On profitability, iRadimed Corporation generates a return on equity (ROE) of 23.45% — well above the market average, a sign of a high-quality business, return on capital employed of 26.04%, an operating margin of 32.40%, a net profit margin of 26.70%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides